Alto Neuroscience Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Alto Neuroscience Inc's ROI in the second quarter of 2026?
Alto Neuroscience Inc recorded a cumulative net loss of $-84 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -41.5%.

Within the Healthcare sector 252 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3548 to 3606.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	23.1 %	3.86 %	-14.82 %	-4.16 %	40.55 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	237	263	173	138	150
Return On Investment (TTM)	-41.5 %	-41.04 %	-40.43 %	-40.17 %	-39.34 %
ANRO's Overall Ranking	# 3606	# 3548	# 2930	# 3129	# 2888
Seq. Investment Change TTM	12.1 %	15.74 %	0.94 %	-6.01 %	-5.42 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-84	-74	-63	-62	-65

ANRO Company Profile >> Back to ANRO Roi Comparisons >> See Annual ANRO Return On Investment

Return On Investment ANRO's Ranking
Within:	No.
Industry	# 87
Sector	# 253
Overall	# 3606

Return On Investment Statistics
High	Average	Low
-26.58 %	-37.34 %	-41.5 %
(Mar 31 2024)		(Jun 30 2026)

Financial Statements
Alto Neuroscience Inc's II. Quarter Investments	$ 237 Millions	ANRO's Balance sheet
Alto Neuroscience Inc's II. Quarter Income	$ -28 Millions	Quarterly ANRO's Income Statement
ANRO's Income by Division		See ANRO's Income by Division

ANRO Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024
Total Investments in Millions	173	168	0	0	0
Y / Y Investment Growth	3.48 %	-	-	-	-
Net Income in Millions	-63	-61	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-36.48 %	-36.67 %	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ANRO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ANRO's Competitors
Subscribers only: Roi for Alto Neuroscience Inc's Suppliers
Subscribers only: Return On Investment for ANRO's Customers

Other Ratios
ANRO's Roa	ANRO's Inventory Turnover Ratio	ANRO's Growth Rates	ANRO's Dividend Statistics
	ANRO's Profitability Ratios	ANRO's Asset Turnover Ratio	ANRO's Dividend Growth
ANRO's Roe	ANRO's Valuation Ratios	ANRO's Financial Strength Ratios	ANRO's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:42:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.